Reactivation of cytomegalovirus after lung transplantation : a basic and experimental study in rats.

肺移植后巨细胞病毒的再激活:大鼠的基础和实验研究。

基本信息

  • 批准号:
    04454340
  • 负责人:
  • 金额:
    $ 4.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1994
  • 项目状态:
    已结题

项目摘要

Cytomegalovirus (CMV) infection is a serious complication and sometimes fatal in patients after bone marrow, heart and lung transplantation. In most of the cases, the cause of CMV infection is reactivation of latent virus in the donor organ or in the recipient. The objective of this study was to investigate the mechanism of reactivation of latent CMV after lung transplantation. MATERIALS & METHODS : For the purpose of this study, we established an animal model of CMV infection in rats. We studied interaction between chronic rejection response and rat CMV (RCMV) infection using this model. Orthotopic left lung transplantation was performed in a MHC different rat strain combination (Brown Norway/Lewis), and high dosage cyclosporing (25 mg/kg/day i.m.) was given on dat 2,3 and 4 inducing permanent acceptance of lung allografts. Four months afetr the transplantation, acute RCMV infection was induced by inoculation of 10^5 pfu of RCMV,and rats were killed on day 7 and 21 after the infection. We studied distribution pattern of RCMV antigens in various organs immunohistochemically. RESULTS : 1.In allotransplants 21 days after RCMV infection, 2/3 of the lung allografts showed histological change of chronic rejection and bronchiolitis obliterans. 2.Strongly RCMV antigens positive cells were detected in this lesion. 3.The histological change of bronchiolitis obliterans distributed unevenly, and RCMV antigens positive cells were not observed in other area without histological change of chronic rejection or bronchiolitis obliterans. CONCLUSINS : It seemed that chronic rejection response was an inducing factor of the reactivation of latent CMV.It was also suggested that CMV infection playd an important role in the development of histological change of bronchiolitis obliterans after lung transplantation.
巨细胞病毒(CMV)感染是骨髓、心脏和肺移植后的严重并发症,有时甚至致命。在大多数情况下,CMV感染的原因是供体器官或受体中潜伏病毒的再激活。本研究的目的是探讨肺移植术后潜伏期巨细胞病毒再激活的机制。材料与方法:建立巨细胞病毒感染大鼠模型。我们利用该模型研究了慢性排斥反应与大鼠巨细胞病毒(RCMV)感染之间的相互作用。在MHC不同大鼠品系组合(Brown Norway/刘易斯)中进行原位左肺移植,并在24小时内给予高剂量环孢菌素(25 mg/kg/天i. m.)诱导肺同种异体移植物的永久接受。移植后4个月,通过接种10^5 pfu的RCMV诱导急性RCMV感染,并在感染后第7天和第21天处死大鼠。用免疫组织化学方法研究了RCMV抗原在各器官中的分布规律。研究结果:1.RCMV感染后21天,2/3的移植肺出现慢性排斥反应和闭塞性细支气管炎的组织学改变。2. RCMV抗原阳性细胞。3.闭塞性细支气管炎的组织学改变分布不均匀,在无慢性排斥反应或闭塞性细支气管炎组织学改变的其他区域未观察到RCMV抗原阳性细胞。结论:提示慢性排斥反应可能是潜伏期CMV再激活的诱发因素,CMV感染在肺移植后闭塞性细支气管炎组织学改变的发生中起重要作用。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Yagyu,M.Takeshita,T.Otsuka,H.Kubota,A.Furuse,P.J.C.van Breda Vriesman: "Reactivation of latent cytomegalovirus in allografts : Comparison of lung graft and kidney graft in rats." Transplantation Proceedings. 26. 2343-2344 (1994)
K.Yagyu、M.Takeshita、T.Otsuka、H.Kubota、A.Furuse、P.J.C.van Breda Vriesman:“同种异体移植物中潜伏巨细胞病毒的再激活:大鼠肺移植物和肾移植物的比较。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Yagyu,G.Steinhoff,A.M.Duijvestijn,C.A Bruggiman,H.Matsumoto,PJ.C van Breda Vriesman: "Reactivation of rat cytomegalovirus in lung allografts:an experimental and immunohistochemical study in rats." The Journal of Heart and Lung Translantation. 11. 1031-1
K.Yagyu、G.Steinhoff、A.M.Duijvestijn、C.A Bruggiman、H.Matsumoto、PJ.C van Breda Vriesman:“同种异体肺移植物中大鼠巨细胞病毒的再激活:大鼠实验和免疫组织化学研究。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Yagyu,G-Stenhoff,A.M.Duijvestijn,C.A.Bruggeman,H.Matsumoto,P.J.C.van Breda Vriesman.: "Reactivation of rat cytomegalovirus in lung allografts : an experimental and immunohisto chemical study in rats." The Journal of Heart and Lung Transplantation. 11. 1
K.Yagyu、G-Stenhoff、A.M.Duijvestijn、C.A.Bruggeman、H.Matsumoto、P.J.C.van Breda Vriesman.:“同种异体肺移植物中大鼠巨细胞病毒的再激活:大鼠实验和免疫组织化学研究。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Yagyu, G.Steinhoff, A.M.Duijvestijn, C.A.Bruggeman, H.Matsumoto, P.J.C.van Breda Vriesman: "Reactivation of rat cytomegalovirus in lung allografts ; An experimental and immunohistochemical study in rats" The Journal of Heart and Lung Transplantation. Vo
K.Yagyu、G.Steinhoff、A.M.Duijvestijn、C.A.Bruggeman、H.Matsumoto、P.J.C.van Breda Vriesman:“同种异体肺移植物中大鼠巨细胞病毒的再激活;大鼠实验和免疫组织化学研究”心肺移植杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Yagyu, P.J.C.van Breda Vriesman, A.M.Duijvestijn, C.A.Bruggeman, G.Steinhoff: "Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts" Transplantation Proceedings. Vol.25
K.Yagyu、P.J.C.van Breda Vriesman、A.M.Duijvestijn、C.A.Bruggeman、G.Steinhoff:“大鼠肺同种异体移植物中巨细胞病毒的再激活伴急性排斥反应和巨细胞病毒感染伴闭塞性细支气管炎”移植论文集。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAGYU Kuniyoshi其他文献

YAGYU Kuniyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAGYU Kuniyoshi', 18)}}的其他基金

Differential diagnosis between acute rejection and infection after lung transplantation : a basic, experimental and immunohistochemical study in rats.
肺移植后急性排斥和感染的鉴别诊断:大鼠的基础、实验和免疫组织化学研究。
  • 批准号:
    02404055
  • 财政年份:
    1990
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)

相似海外基金

Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation
将来自免疫活性干细胞供体的疫苗诱导的免疫力转移作为抗病毒免疫疗法,以保护高危移植受者免受巨细胞病毒再激活
  • 批准号:
    10659635
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
MICA Investigating the role of cytomegalovirus reactivation in amplifying monocyte driven renal damage in active ANCA associated vasculitis
MICA 研究巨细胞病毒再激活在放大活动性 ANCA 相关血管炎中单核细胞驱动的肾损伤中的作用
  • 批准号:
    MR/X006964/1
  • 财政年份:
    2023
  • 资助金额:
    $ 4.22万
  • 项目类别:
    Fellowship
Targeting Ischemia/Reperfusion Stress to Inhibit Cytomegalovirus Reactivation After Lung Transplant
针对肺移植后缺血/再灌注应激抑制巨细胞病毒再激活
  • 批准号:
    10453246
  • 财政年份:
    2022
  • 资助金额:
    $ 4.22万
  • 项目类别:
2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
2/2 更昔洛韦预防急性呼吸衰竭和脓毒症患者巨细胞病毒再激活
  • 批准号:
    9976960
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
1/2 更昔洛韦预防急性呼吸衰竭和脓毒症患者巨细胞病毒再激活
  • 批准号:
    10701856
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
1/2 更昔洛韦预防急性呼吸衰竭和脓毒症患者巨细胞病毒再激活
  • 批准号:
    10656536
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
1/2 更昔洛韦预防急性呼吸衰竭和脓毒症患者巨细胞病毒再激活
  • 批准号:
    9976966
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
1/2 更昔洛韦预防急性呼吸衰竭和脓毒症患者巨细胞病毒再激活
  • 批准号:
    10274819
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
2/2 更昔洛韦预防急性呼吸衰竭和脓毒症患者巨细胞病毒再激活
  • 批准号:
    10652658
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
2/2 更昔洛韦预防急性呼吸衰竭和脓毒症患者巨细胞病毒再激活
  • 批准号:
    10264812
  • 财政年份:
    2020
  • 资助金额:
    $ 4.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了